DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study

Blood. 2017 Jul 27;130(4):554-557. doi: 10.1182/blood-2016-12-755496. Epub 2017 May 18.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anaplastic Lymphoma Kinase
  • Biopsy
  • Denmark / epidemiology
  • Dual-Specificity Phosphatases / genetics*
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Kaplan-Meier Estimate
  • Lymphoma, Large-Cell, Anaplastic / genetics*
  • Lymphoma, Large-Cell, Anaplastic / mortality
  • Lymphoma, Large-Cell, Anaplastic / pathology
  • Male
  • Middle Aged
  • Mitogen-Activated Protein Kinase Phosphatases / genetics*
  • Oncogene Proteins, Fusion / analysis
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Receptor Protein-Tyrosine Kinases / analysis
  • Single-Blind Method
  • Transcription Factors / genetics*
  • Tumor Suppressor Proteins / genetics*
  • Young Adult

Substances

  • Oncogene Proteins, Fusion
  • TP63 protein, human
  • Transcription Factors
  • Tumor Suppressor Proteins
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases
  • Mitogen-Activated Protein Kinase Phosphatases
  • DUSP22 protein, human
  • Dual-Specificity Phosphatases